Strategic investment reinforces Europe as a core pillar of GenScript's global R&D and production network, following recent U.S. facility expansion. DELFT, Netherlands, March 12, 2026 /PRNewswire/ -- ...
The rapid advancement of cell and ex vivo gene therapies demands scalable, efficient, and regulatory-compliant manufacturing solutions. As manufacturing complexities grow, ensuring consistency, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results